Association of health insurance coverage disruptions and breast and colorectal cancer screening
Cancer · 2025
DOI: 10.1002/cncr.35584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Kewei Sylvia Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Breast Neoplasms, Insurance Coverage, Early Detection of Cancer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Health insurance coverage is critical for ensuring access to recommended health care in the United States. This study investigated the associations of health insurance coverage disruptions, also known as coverage churn, and receipt of breast and colorectal cancer screening.
Methods
Adults who were age‐eligible and younger than 65 years (range, 50–64 years) for breast ( n = 17,128 women) and colorectal ( n = 32,562 individuals) cancer screening were identified from 5 years of the National Health Interview Survey. Adults were categorized into five groups based on insurance type at survey (private, public, none) and prior coverage disruptions within the past year. Screening outcomes included: (1) ever‐screened, (2) past‐year screening, and (3) guideline‐concordant screening. Separate multivariate logistic regression models were used to evaluate the associations between insurance coverage disruptions and cancer screening.
Results
Among adults who had coverage at the time of the survey, 3.1% with private insurance and 6.5% with public insurance reported prior coverage disruptions. Individuals without health insurance coverage had the lowest level of screening. Among individuals who had private coverage, prior disruptions were associated with lower guideline‐concordant screening in adjusted analyses (breast cancer screening: adjusted prevalence ratio [aPR], 0.82; 95% confidence interval [CI], 0.75–0.89; colorectal cancer screening: aPR, 0.78; 95% CI, 0.72–0.86); among those who had public coverage, prior disruptions were also associated with lower guideline‐concordant breast cancer screening (aPR, 0.73; 95% CI, 0.60–0.89) and colorectal cancer screening (aPR, 0.84; 95% CI, 0.72–0.99).
Conclusions
Health insurance coverage disruptions were associated with lower past‐year and guideline‐concordant breast and colorectal cancer screening. The current findings underscore the importance of stable health insurance coverage to improve cancer screening and early detection when treatment is most effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
ORCID-Profile: Kewei Sylvia Shi, Xuesong Han, Jingxuan Zhao, K Robin Yabroff
Zitieren
APA
Shi, K. S., Han, X., Star, J., Zhao, J., & Yabroff, K. R. (2025). Association of health insurance coverage disruptions and breast and colorectal cancer screening. Cancer. https://doi.org/10.1002/cncr.35584
Vancouver
Shi KS, Han X, Star J, Zhao J, Yabroff KR. Association of health insurance coverage disruptions and breast and colorectal cancer screening. Cancer. 2025. doi:10.1002/cncr.35584
BibTeX
@article{Shi2025,
author = {Shi, Kewei Sylvia and Han, Xuesong and Star, Jessica and Zhao, Jingxuan and Yabroff, K Robin},
title = {Association of health insurance coverage disruptions and breast and colorectal cancer screening},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35584}
}
EUVIMED